Replies to post #309255 on NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

Sounds a bit harsh but every bit of what you say is true, sadly. It has always been enormously difficult for even the largest foreign companies to make any money in the huge Chinese domestic market. The Chinese internal security apparatus exerts extreme repressive control and Xi Jinping is a total disaster for human rights especially for any minorities especially the Tibetians (continuing the policies of the last 20-30 years) and the large Islamic minorities, commercial rights of foreign capital within China, for freedom and human rights of Hong Kongers and for countries around the world esp in Asia and Africa getting Chinese 'financial aid' usually meaning being small partners losing national sovereignty over part of their territories to onerous development JVs which aren't commercially viable but act as trojan horses for the Chinese to take legal control of land and facilities like ports after large loans go into default.

The Chinese people generally fully buy into the national pride rhetoric of China now being strong after having been exploited and surrounded by enemies harkening back to the century or more to 1945 of Chinses loss of sovereignty to Western countries and then being largely occupied by Japan. To the extent there is any opposition to the CPC line and support for Xi as president for life, well anybody who is willing to express it is subject to quick arrest, trial in a kangaroo court and very harsh punishment. All this is very, very sad but true.

[XenaLives]

WRONG "There is no national healthcare in China, so only wealthy people will get it anyway."

Abstract
China successfully achieved universal health insurance coverage in 2011, representing the largest expansion of insurance coverage in human history. While the achievement is widely recognized, it is still largely unexplored why China was able to attain it within a short period. This study aims to fill the gap. Through a systematic political and socio-economic analysis, it identifies seven major drivers for China's success, including (1) the SARS outbreak as a wake-up call, (2) strong public support for government intervention in health care, (3) renewed political commitment from top leaders, (4) heavy government subsidies, (5) fiscal capacity backed by China's economic power, (6) financial and political responsibilities delegated to local governments and (7) programmatic implementation strategy. Three of the factors seem to be unique to China (i.e., the SARS outbreak, the delegation, and the programmatic strategy.) while the other factors are commonly found in other countries’ insurance expansion experiences. This study also discusses challenges and recommendations for China's health financing, such as reducing financial risk as an immediate task, equalizing benefit across insurance programs as a long-term goal, improving quality by tying provider payment to performance, and controlling costs through coordinated reform initiatives. Finally, it draws lessons for other developing countries.

https://www.sciencedirect.com/science/article/pii/S0168851015001864